Preferential radiosensitization to glioblastoma cancer stem cell‑like cells by a Hsp90 inhibitor, N‑vinylpyrrolidone‑AUY922-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preferential radiosensitization to glioblastoma cancer stem cell‑like cells by a Hsp90 inhibitor, N‑vinylpyrrolidone‑AUY922

Published:2022-01-31 Issue:3 Volume:23 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Tani Toshiaki¹,Tojo Naomi²,Ohnishi Ken²

Affiliation:

1. Radiological Technology Section, QST Hospital, National Institutes for Quantum and Radiological Science and Technology, Chiba 263‑8555, Japan

2. Department of Biology, Ibaraki Prefectural University of Health Sciences, Inashiki, Ibaraki 300‑0394, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference30 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial;Stupp;Lancet Oncol,2009

2. Identification of human brain tumour initiating cells;Singh;Nature,2004

3. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response;Bao;Nature,2006

4. Chemoresistance of glioblastoma cancer stem cells-much more complex than expected;Beier;Mol Cancer,2011

5. Radioresistance of glioma stem cells: Intrinsic characteristic or property of the ‘microenvironment-stem cell unit’?;Mannino;Mol Oncol,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Temozolomide Combined with Intensity Modulated Radiation Therapy on Serum Factor, Immune Function and Clinical Efficacy in Postoperative Glioma Patients;Radiation Research;2023-05-22

2. Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration;Metabolites;2022-11-21

3. Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials;Cancers;2022-11-04

4. Small Molecules and Immunotherapy Agents for Enhancing Radiotherapy in Glioblastoma;Biomedicines;2022-07-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3